Inventor · disambiguated record
Richard Flavell
Also filed as: FLAVELL RICHARD · FLAVELL RICHARD A
50 granted patents·20 pending applications·514 citations·filing 1993–2024
98Inventor score
Top patents by PatentIndex Score
70 records- 0197US10433527B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Oct 8, 2019·13 cites·12 claims
- 0297US8847004B2Humanized M-CSF miceMURPHY ANDREW J·Filed 2012·Granted Sep 30, 2014·28 cites·16 claims
- 0397US8692052B2Genetically modified mice and engraftmentSTEVENS SEAN·Filed 2012·Granted Apr 8, 2014·22 cites·16 claims
- 0497US8541646B2Genetically modified mice and engraftmentSTEVENS SEAN·Filed 2010·Granted Sep 24, 2013·39 cites·17 claims
- 0596US9986724B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Jun 5, 2018·17 cites·14 claims
- 0696US9655352B2Humanized M-CSF miceREGENERON PHARMA·Filed 2014·Granted May 23, 2017·19 cites·6 claims
- 0796US9554563B2Genetically modified mice and engraftmentREGENERON PHARMA·Filed 2013·Granted Jan 31, 2017·20 cites·25 claims
- 0896US9301509B2Genetically modified mice and engraftmentSTEVENS SEAN·Filed 2012·Granted Apr 5, 2016·21 cites·18 claims
- 0995US9901082B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2013·Granted Feb 27, 2018·17 cites·6 claims
- 1094US10603276B2Nanolipogel vehicles for controlled delivery of different pharmaceutical agentsUNIV YALE·Filed 2018·Granted Mar 31, 2020·6 cites·20 claims
- 1194US9820476B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2013·Granted Nov 21, 2017·12 cites·15 claims
- 1293US9402377B2Human SIRPAalpha transgenic animals and their methods of useFLAVELL RICHARD A·Filed 2011·Granted Aug 2, 2016·33 cites·10 claims
- 1392US11051499B2Genetically modified mice and engraftmentREGENERON PHARMA·Filed 2019·Granted Jul 6, 2021·3 cites·20 claims
- 1490US11173119B2Nanolipogel vehicles for controlled delivery of different pharmaceutical agentsUNIV YALE·Filed 2019·Granted Nov 16, 2021·2 cites·14 claims
- 1590US10278374B2Genetically modified mice and engraftmentREGENERON PHARMA·Filed 2017·Granted May 7, 2019·3 cites·20 claims
- 1689US11026408B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2019·Granted Jun 8, 2021·2 cites·17 claims
- 1789US2025072406A1Humanized M-CSF MiceREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1889US2025072405A1Genetically Modified Non-Human Animals And Methods Of Use ThereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1988US9610250B2Nanolipogel vehicles for controlled delivery of different pharmaceutical agentsUNIV YALE·Filed 2013·Granted Apr 4, 2017·8 cites·48 claims
- 2087US10561126B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Feb 18, 2020·5 cites·22 claims
- 2186US2024099278A1Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2285US10428392B2Compositions and methods for identifying secretory antibody-bound microbesUNIV YALE·Filed 2017·Granted Oct 1, 2019·4 cites·18 claims
- 2384US10774392B2Compositions and methods for identifying secretory antibody-bound microbesUNIV YALE·Filed 2019·Granted Sep 15, 2020·1 cites·22 claims
- 2484US9758838B2Compositions and methods for identifying secretory antibody-bound microbesUNIV YALE·Filed 2014·Granted Sep 12, 2017·6 cites·12 claims
- 2583US10123518B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Nov 13, 2018·3 cites·28 claims
- 2681US6916654B1Universal donor cellsUNIV YALE·Filed 2000·Granted Jul 12, 2005·22 cites·13 claims
- 2780US5618533AFlagellin-based polypeptides for the diagnosis of lyme diseaseUNIV YALE·Filed 1993·Granted Apr 8, 1997·53 cites·11 claims
- 2879US12156939B2Nanolipogel vehicles for controlled delivery of different pharmaceutical agentsUNIV YALE·Filed 2021·Granted Dec 3, 2024·0 cites·13 claims
- 2979US9095126B2Targeting TGF-β as a therapy for Alzheimer's diseaseFLAVELL RICHARD A·Filed 2009·Granted Aug 4, 2015·6 cites·3 claims
- 3078US6100443AUniversal donor cellsOKLAHOMA MED RES FOUND·Filed 1995·Granted Aug 8, 2000·31 cites·17 claims
- 3177US12402611B2Genetically modified mice and engraftmentREGENERON PHARMA·Filed 2021·Granted Sep 2, 2025·0 cites·8 claims
- 3277US12127537B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Oct 29, 2024·0 cites·18 claims
- 3377US10925953B2Compositions and methods for treating an inflammatory disease or disorderUNIV YALE·Filed 2015·Granted Feb 23, 2021·2 cites·14 claims
- 3477US2023292721A1Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 3576US5747294ACompositions and methods for the prevention and diagnosis of lyme diseaseUNIV YALE·Filed 1994·Granted May 5, 1998·25 cites·9 claims
- 3674US12127536B2Humanized M-CSF miceREGENERON PHARMA·Filed 2020·Granted Oct 29, 2024·0 cites·21 claims
- 3774US11778995B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Oct 10, 2023·0 cites·11 claims
- 3874US10463028B2Genetically modified non-human animals expressing human EPOREGENERON PHARMA·Filed 2015·Granted Nov 5, 2019·1 cites·19 claims
- 3974US9839208B2Human SIRPα transgenic mice and their methods of useUNIV YALE·Filed 2016·Granted Dec 12, 2017·1 cites·17 claims
- 4072US11299790B2Compositions and methods for identifying secretory antibody-bound microbesUNIV YALE·Filed 2020·Granted Apr 12, 2022·0 cites·10 claims
- 4170US5705732AUniversal donor cellsOKLAHOMA MED RES FOUND·Filed 1993·Granted Jan 6, 1998·24 cites·5 claims
- 4269US10785968B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2017·Granted Sep 29, 2020·0 cites·10 claims
- 4367US10785966B2Humanized M-CSF miceREGENERON PHARMA·Filed 2017·Granted Sep 29, 2020·0 cites·11 claims
- 4464US2025154238A1Methods and compositions for treating and preventing fibrosisUNIV YALE·Filed 2023·Application pending·0 cites
- 4564US2018020647A1Genetically Modified Non-Human Animals And Methods Of Use ThereofREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 4664US2024074414A1Genetically modified non-human animals expressing human epoREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 4762US11576356B2Genetically modified non-human animals and methods of use thereofREGENEREN PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·20 claims
- 4862US6197301B1Compositions and methods for the prevention and diagnosis of Lyme diseaseUNIV YALE·Filed 1995·Granted Mar 6, 2001·21 cites·86 claims
- 4961US7323616B2Genetically altered mice deficient in functional caspase-9VERTEX PHARMA·Filed 2000·Granted Jan 29, 2008·1 cites·10 claims
- 5061US2021170014A1Compositions and methods for treating an inflammatory disease or disorderUNIV YALE·Filed 2021·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard Flavell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →